Sabine Schumann
Head of Communications
EIT Health

Download the flier


Successes Listed

Next-level Alzheimer’s screening
Bringing mobile technologies to everyday practice
RAS-Q: The lung in a backpack
Treating cancer using anti-Myc peptides
Sustainable course: Advanced Management Programme on Health Innovation
Systematically improving chronic joint pain management across Europe
Removing bottlenecks that prevent use of Antibody Drug Conjugates
Non-invasive neural stimulator for movement disorders
Online course equips online learners to maximise healthcare data
Eliminating pneumothorax during lung biopsy
Innovating to solve global health challenges
Bringing intelligence to genetic data
An artificial pancreas for Type 1 diabetes patients
Self-management systems for respiratory diseases
Smart software for healthcare support
Innovative design-based methods in the workplace
Hundreds of citizens learn about health and active ageing, and provide essential feedback
Summer school using real-life cases to catalyse innovation finds new funders
A collaborative approach to innovation in diabetes care
Citizen-centred training for healthcare professionals
Improving the measurement of joint mobility
A more natural solution to chronic constipation
Clinical Innovation Fellowship spin-off seeks to improve medical tube success
Driving health innovation for the future
Empowering women entrepreneurs in health innovation
Smart-up Lab students and other present their ideas to investors
Improved prostate cancer diagnostics
State-of-the-art tool for dementia risk assessment
Device offers inexpensive alternative to surgery for common prostate problem
New platform allows everyone to link and mine life-changing data faster, smarter and simpler
Developing next-generation biological drugs for treating wounds in skin and mucosa
Non-medicinal soft robotic for the best night’s rest
A Star-Trek like medical device that provides the solution to killing multiresistant bacteria and treating chronic wounds

Success Stories




Bringing intelligence to genetic data

01 March 2018
Header Image
HeartGenetics’s core business is transforming genetic data into actionable knowledge for healthcare professionals, through the combination of software and new genetic tests. The company started in the cardiovascular field with tests for the clinical routine but has since expanded its focus to disease prevention with lifestyle genetic tests (nutrition and fitness).

We are also expanding the way we communicate genetic test results, with the use of web apps.

The company has already started its internationalisation process and has a presence in Portugal, Spain, Italy and Brazil. In 2018, the company will start sales in Poland and Germany, and expand the business in Europe while consolidating sales in existing markets.

Results to date:

In the past two years, Heartgenetics has:

  • developed two genetic tests for lifestyle (nutrition and fitness), including a web app for nutrition;
  • launched three pharmacogenetics tests for cardiology;
  • launched a genetic test for colon cancer pharmacogenetics;
  • had our products certified CE-IVD;
  • started sales in Spain;
  • entered a partnership to pilots in Poland and Germany.

They have also been awarded the following certifications: ISO 9001, ISO 13485, NP 4457, UK NEQAS.


HeartGenetics’ secret is the combination of proprietary algorithms, new genetic tests, and a scalable methodology.

Founded: 2013

Benefits of EIT Health support

Anna Teresa Freitas, CEO of Heartgenetics, explains how EIT Health supports the company: “For Heartgenetics, being selected to participate in EIT Health GoEurope 2016, meant that we were awarded with a €50k grant that allowed us to fund a market study for evaluating the cardiovascular genetics market in Europe, which in turn enabled us to realign our strategy for European markets. The programme also gave us access to a greater network of Portuguese start-ups and entrepreneurs and access to EIT Health partners across Europe.

“The programme enabled us to participate in a one-week immersion programme in the Silicon Valley ecosystem. Through EIT Health GoGlobal, we also had the opportunity to pitch at TRACTION which is the Health 2.0 conference start-up championship. We were the only European company to do so that year. The information and evidence gathered through these experiences guided HeartGenetics to the decision to focus on developing the new vertical of wellness genetics, on brand recognition and European expansion rather than entering the US market immediately. The EIT Health programme supported us in this path towards greater maturity and sustainability.”

Location: Portugal